Novo Nordisk (NVO) announced today that its blockbuster drug Ozempic was approved by the Food and Drug Administration (FDA) as the first GLP-1 treatment for chronic kidney disease among people with type 2 diabetes.Read more…Read More
Author Archives: Michele Kucera
A strike at Costco (COST) is now a real possibility after the union representing thousands of workers voted to authorize it. Read more…Read More
Nina King says that Ozempic’s rise could shift beauty standards away from thinness as it becomes more accessible.Read More
How brands will alert consumers to their products’ compatibility with GLP-1 drugs like Ozempic. Conagra Brands launches first GLP-1 labelling…Read More
Ozempic diabetes Blockbuster weight loss and type 2 diabetes drugs, such as Ozempic, carry a growing list of benefits. These drugs — known as glucagon-like peptide 1 (GLP-1) agonists — can control blood sugar, spur meaningful weight loss, and, in high-risk patients, help prevent heart attacks and strokes. US Food and Drug Administration approvals for […]